Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dextrose/lafyèv

Lyen an sove nan clipboard la
9 rezilta yo

Oral Dextrose Formula in Performance of Soccer Athlete

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Male academy soccer players, included in a trial, received two types of solutions (compound of 150 cc dextrose 10% + 20 mM sodium or single 150 cc dextrose 10%) interchangeably, separated within 120 minutes were completed in a counterbalanced, randomized, double-blind, crossover design. The study

Investigating Effects of BOTOX on Weight Loss and Glucose Tolerance in Obese, Type 2 Diabetic Subjects

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Obese subjects (body mass index ≥ 30 kg/m2) with prediabetes or type 2 diabetes will be recruited by solicitation flyers, advertisements, and mass emails. Subjects who do not qualify for bariatric surgery, or subjects who are awaiting insurance approval for a bariatric procedure at the Center of

Nitric Oxide Donor Isosorbide Mono Nitrate for Induction of Labor With Pre-labor Rupture of Membranes

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
- Study Design: Prospective double blinded randomized placebo-controlled Clinical trial - Time plan: Approximately 6 months according to calculated sample size. - study setting: this study will be conducted obstetrics and gynecology department at Cairo university. - study population: patient will be

P. Falciparum Resistance to Artemisinin in Vietnam

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
3.1 Study Design This study is designed as a randomized open label 42-day follow-up study to evaluate the clinical and parasitological responses after treatment of uncomplicated P.falciparum infections with either AS or DHA-PPQ. Symptomatic patients with P.falciparum mono-infections, fulfilling the

Prophylactic Antibiotics Before RFA for HCC

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Patients 1. This cohort study will prospectively enroll HCC patients undergoing RFA in Taipei Veterans General Hospital and Taipei Medical University Hospital. 2. The diagnosis of HCC is established by histology or on the basis of the findings of typical radiologic features in a 4-phase

The Regain of Gastrointestinal Motility After General Anaesthesia Versus Spinal Anaesthesia in Caesarean Section

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The The study protocol was approved by the Scientific Research Committee of the department. Pregnant women with indication for caesarean section were enrolled after providing informed consent. It included 450 patients who had caesarean section and were subdivided into two groups according to a

Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Japanese encephalitis (JE) is the most important epidemic encephalitis worldwide, causing approximately 35-50,000 cases and 10-15,000 deaths annually. Half of the survivors have severe neuropsychiatric sequelae, posing a large socio-economic burden on communities that can ill afford it. JE virus

Single Dose Liposomal Amphotericin B for Visceral Leishmaniasis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Primary Objectives: To evaluate the operational feasibility of delivering point of care, rapid diagnosis with rK39 and treatment with AmBisome® single dose of 10 mg/kg, when administrated at the Primary Health Centers (PHC) setting with regard to feasibility and safety . Secondary objectives: To

A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
ABT-510: In the early 1990s, thrombospondin (TSP-1) was first recognized as an endogenously produced inhibitor of angiogenesis. Since then, thrombospondin has been shown to inhibit neovascularization and tumorigenesis in numerous mouse models. Its anti- angiogenesis properties have been localized to
Antre nan paj
facebook nou an

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

  • Travay nan 55 lang
  • Geri èrbal te apiye nan syans
  • Remèd fèy rekonesans pa imaj
  • Kat entèaktif GPS - tag zèb sou kote (vini byento)
  • Li piblikasyon syantifik ki gen rapò ak rechèch ou an
  • Search remèd fèy medsin pa efè yo
  • Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

Google Play badgeApp Store badge